FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Preferred Pharmaceuticals Allopurinol Tablets 100mg Recall

Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc

Preferred Pharmaceuticals, Inc. · Anaheim, CA

Risk level
Class II
Reported by FDA
Feb 1, 2023
Recall ID
D-0173-2023
Check your lot numberHow we source this data

Summary

Preferred Pharmaceuticals recalled Allopurinol Tablets 100mg starting Jan 16, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0173-2023 on Feb 1, 2023. Reason: Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet. Status: Terminated.

Why it was recalled

Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.

Product description

Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.

Lot numbers, UPCs & expiration codes

Lot: K3022Q, Expiration date: 3/31/2025

Where it was sold

IN

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0173-2023
Classification
Class II
Status
Terminated
Recall initiated
Jan 16, 2023
FDA report date
Feb 1, 2023
Quantity
9 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Preferred Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0173-2023, exactly as published.

Show all FDA fields
City
Anaheim
State
CA
Status
Terminated
Country
United States
Event ID
91531
Address
1250 N Lakeview Ave Ste O
Code information
Lot: K3022Q, Expiration date: 3/31/2025
Postal code
92807-1801
Report date
Feb 1, 2023
Product type
Drugs
Recall number
D-0173-2023
Classification
Class II
Recalling firm
Preferred Pharmaceuticals, Inc.
Product quantity
9 bottles
Termination date
Apr 14, 2023
Reason for recall
Presence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of the tablet.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.
Distribution pattern
IN
Recall initiation date
Jan 16, 2023
Initial firm notification
Letter
Center classification date
Jan 23, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0173-2023, published Feb 1, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls